Huifang Lv, Yunduan He, Caiyun Nie, Beibei Chen, Weifeng Xu, Jianzheng Wang, Jing Zhao, Xiaobing Chen. "Open-label, single-arm, single-center phase 1b/2 clinical study of fruquintinib combined with trastuzumab and XELOX in the first-line treatment of advanced HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.tps4203